How can we help you today?

Kirin Health Science Australia Pty Ltd acquisition Blackmores Limited (BKL) – August 2023

The acquisition of Blackmores Limited (BKL) by Kirin Health Science Australia Pty Ltd, schemes is now legally effective. Blackmores Limited (BKL) has been suspended from trading as at 21 July 2023. The scheme record date is 2 August 2023.  Shareholders will receive $91.71 per  Blackmores Limited (BKL) security and a fully franked special dividend of $3.29 per share.

The ATO class ruling can be seen at this link:

To account for the acquisition by Kirin Health Science Australia Pty Ltd, in the Stock Doctor Portfolio Manager, please see the instructions below:

  1. Navigate to the portfolio containing Blackmores Limited (BKL)
  2. In the 'Securities Held' tab, under the Securities Held section, please click on BKL and this will take you to the BKL transaction securities screen.
  3. Scroll down to the “Trades and Adjustments” area
  4. Click on the ‘New Sell” button in red.

Please enter in the following details in the trade window:

Date: 10/8/2023

Quantity: Enter the number of BKL shares held

Price: $ 91.71

Fees: 0

Then click the Save button, found in the bottom right-hand corner.

Below is the dialogue box:

The fully franked special dividend, will automatically appear in the “Income and expenses” area.

You have now accounted for the Scheme of arrangement for BKL.

Our team in the office are ready and willing to assist you with any questions you have about any of the content above. Please give us a call on 1300 676 333 or email us at with any questions you may have. 

However, we are not licensed to provide tax advice and therefore anything which relates to tax or your personal circumstances we will not be able to answer. In order to have personal tax or finance questions answered, you will need to seek the services of a licensed practitioner who will be qualified to answer your queries.Blackmore